Erasca【ERAS】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

2.54

買値

2.29

売値

2.60

出来高

2,198,582

2.435 日の範囲 2.59

1.64 52 週間の範囲 3.45

時価総額

718.127M

前日終値

2.45

始値

2.47

時刻

836

2.54

(priorref)

最終取引時間

財務取引量

US$ 5,585,873

VWAP

2.5407

平均取引量 (3 か月)

1,461,434

発行済株式数

282,727,282

配当利回り

PER

-5.74

1 株当たり利益 (EPS)

-0.44

歳入

純利益

-125.04M

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage progr... Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage programs (CNS-penetrant KRAS G12C and EGFR inhibitors), and seven discovery-stage programs targeting other key oncogenic drivers. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.erasca.com

本社

Wilmington, Delaware, USA

設立

Erasca Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker ERAS. The last closing price for Erasca was US$2.45. Over the last year, Erasca shares have traded in a share price range of US$ 1.64 to US$ 3.45.

Erasca currently has 282,727,282 shares in issue. The market capitalisation of Erasca is US$692.68 million. Erasca has a price to earnings ratio (PE ratio) of -5.74.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.09	-3.42205323194	2.63	2.67	2.39	1767094	2.51259239	CS
4	-0.08	-3.0534351145	2.62	3.3	2.39	1395537	2.79886743	CS
12	-0.17	-6.27306273063	2.71	3.305	2.39	1461434	2.78397446	CS
26	0.5	24.5098039216	2.04	3.45	2.01	1962340	2.75714982	CS
52	0.57	28.9340101523	1.97	3.45	1.64	1587920	2.55455809	CS
156	-12.1	-82.650273224	14.64	16.005	1.51	1055991	3.92840752	CS
260	-13.36	-84.0251572327	15.9	24.47	1.51	973715	4.70497325	CS

ERAS - Frequently Asked Questions (FAQ)

What is the current Erasca share price?

The current share price of Erasca is US$ 2.54

How many Erasca shares are in issue?

Erasca has 282,727,282 shares in issue

What is the market cap of Erasca?

The market capitalisation of Erasca is USD 692.68M

What is the 1 year trading range for Erasca share price?

Erasca has traded in the range of US$ 1.64 to US$ 3.45 during the past year

What is the PE ratio of Erasca?

The price to earnings ratio of Erasca is -5.74

What is the reporting currency for Erasca?

Erasca reports financial results in USD

What is the latest annual profit for Erasca?

The latest annual profit of Erasca is USD -125.04M

What is the registered address of Erasca?

The registered address for Erasca is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Erasca website address?

The website address for Erasca is www.erasca.com

Which industry sector does Erasca operate in?

Erasca operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
MYSZMy Size Inc	US$ 4.2001 (211.12%)	121.03M
NVNINVNI Group Ltd	US$ 8.26 (209.36%)	78.06M
TPICTPI Composites Inc	US$ 2.45 (100.82%)	34M
ICGIntchains Group Ltd	US$ 8.77 (88.60%)	527.94k
HSDTHelius Medical Technologies Inc	US$ 0.884851 (84.34%)	121.95M
CYNCYNGN Inc	US$ 0.4603 (-71.41%)	27.91M
MTEMMolecular Templates Inc	US$ 0.1502 (-57.09%)	8.75M
PRFXPainReform Ltd	US$ 5.15 (-53.85%)	2.94M
GALTGalectin Therapeutics Inc	US$ 1.03 (-48.50%)	9.27M
BCABBioAtla Inc	US$ 0.6923 (-41.82%)	6.25M
EDBLEdible Garden AG Inc	US$ 0.24 (65.06%)	354.33M
NVDANVIDIA Corporation	US$ 134.70 (3.08%)	310.19M
APTOAptose Biosciences Inc	US$ 0.28 (64.51%)	306.25M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.606999 (6.49%)	293.22M
PLTRPalantir Technologies Inc	US$ 80.55 (8.54%)	281.23M